Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.2061
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
0.09
Today|||52-Week Range
0.65
+40.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization109.0K20.0K19.0K9.0K
 
 
 
 
 
 
Operating ExpensesGross Income-109.0K-20.0K-19.0K-9.0K
 
 
 
 
 
General Expenses12.5M13.7M13.7M13.8M
 
 
 
 
 
Research And Development7.4M9.1M8.8M10.5M
 
 
 
 
 
Total Operating Expenses12.7M13.7M13.8M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.7M-13.7M-13.8M-13.8M
 
 
 
 
 
Other Expenses-3.0K1.0K-1.0K-5.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.6M-13.7M-13.7M-13.8M
 
 
 
 
 
Net Income-12.6M-13.7M-13.7M-13.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.0M25.2M26.5M26.5M
 
 
 
 
 
Shares To Calculate EPS Diluted17.0M25.2M26.5M26.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.75-$0.54-$0.51-$0.52
 
 
 
 
 
EPS Diluted-$0.75-$0.54-$0.51-$0.52